agilon health, inc. - Common stock, $0.01 par value (AGL)

CUSIP: 00857U107

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
-4,898,108
Put/Call ratio
63%
SEC-reported price per share
$17.34
Number of holders
185
Value change
-$98,821,035
Number of buys
127
Open additional details 1 more signal available
Number of sells
86
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,608,126

Security key

00857U107

Report period

Q2 2023

Institutions

185

Top holders

10

Ownership snapshot

Top reported holders of AGL - agilon health, inc. - Common stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CD&R Investment Associate...
Disclosed value leader
Clayton, Dubilier & Rice,...
Comparable rows
0/15
Latest evidence
18 May 2023
3/4/5 13F Highest disclosed value: $4,622,018,565 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Clayton, Dubilier & Rice, LLC has the largest disclosed position value at $4.62B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Clayton, Dubilier & Rice, LLC's linked filing trail.
Disclosed position value Top 5
CD&R Investment Associates IX, Ltd. $1.12B
Clayton, Dubilier & Rice, LLC $4.62B
Capital World Investors $1.01B
MORGAN STANLEY $869.67M
WELLINGTON MANAGEMENT GROUP LLP $483.22M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CD&R Investment Associates IX, Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$1,122,000,000
100,000,000 shares
— 18 May 2023
Clayton, Dubilier & Rice, LLC
13F
Company
13F
—
denominator unverified
$4,622,018,565
194,611,308 shares
— 31 Mar 2023
Capital World Investors
13F
Company
13F
—
denominator unverified
$1,007,854,311
42,435,971 shares
— 31 Mar 2023
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$869,667,489
36,617,578 shares
— 31 Mar 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$483,218,808
20,346,055 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$456,860,961
19,236,251 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
185
Shares
441,924,134
Rows available
185
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
201
Q2 2023 holders
185
Holder diff
-16
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .